ArticleCancers2023

CDK4/6 Inhibitors Overcome Endocrine ESR1 Mutation-Related Resistance in Metastatic Breast Cancer Patients.

Stefania Crucitta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.